Cargando…

Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations

BACKGROUND: Iron oxide nanoparticles (IONPs) have been extensively studied in different biomedical fields. Recently, the non-cytotoxic concentration of IONPs induced cell-specific response raised concern of their safety. Endothelial cell exposure was unavoidable in their applications, while whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Tao, Du, Lifan, Chen, Bo, Yan, Doudou, Yang, Aiyun, Liu, Jian, Gu, Ning, Meng, Jie, Xu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626375/
https://www.ncbi.nlm.nih.gov/pubmed/31300057
http://dx.doi.org/10.1186/s12989-019-0314-4
_version_ 1783434564161503232
author Wen, Tao
Du, Lifan
Chen, Bo
Yan, Doudou
Yang, Aiyun
Liu, Jian
Gu, Ning
Meng, Jie
Xu, Haiyan
author_facet Wen, Tao
Du, Lifan
Chen, Bo
Yan, Doudou
Yang, Aiyun
Liu, Jian
Gu, Ning
Meng, Jie
Xu, Haiyan
author_sort Wen, Tao
collection PubMed
description BACKGROUND: Iron oxide nanoparticles (IONPs) have been extensively studied in different biomedical fields. Recently, the non-cytotoxic concentration of IONPs induced cell-specific response raised concern of their safety. Endothelial cell exposure was unavoidable in their applications, while whether IONPs affect the phenotype of vascular endothelial cells is largely unknown. In this work, the effect of IONPs on endothelial-to-mesenchymal transition (EndMT) was investigated in vitro and in vivo. RESULTS: The incubation with γ-Fe(2)O(3) nanoparticles modified with polyglucose sorbitol carboxymethyether (PSC-Fe(2)O(3)) at non-cytotoxic concentration induced morphological changes of human umbilical vein endothelial cells (HUVECs) from cobblestone-like to spindle mesenchymal-like morphology, while PSC-Fe(2)O(3) mostly stay in the culture medium and intercellular space. At the same time, the endothelial marker CD31 and VE-cadherin was decreased along with the inhibitory of angiogenesis properties of HUVEC. Meanwhile, the mesenchymal marker α-smooth muscle actin (α-SMA) and fibroblast specific protein (FSP) was up regulated significantly, and the migration ability of the cells was enhanced. When ROS scavenger mannitol or AA was supplemented, the EndMT was rescued. Results from the in vivo study showed that, expression of CD31 was decreased and α-SMA increased in the liver, spleen and kidney of mice given PSC-Fe(2)O(3), and the density of collagen fibers in the liver sinusoid of mice was increased. The supplementary mannitol or AA could reverse the degree of EndMT in the tissues. Mechanistic study in vitro indicated that the level of extracellular hydroxyl radicals (·OH) was up regulated significantly by PSC-Fe(2)O(3), which induced the response of intracellular ROS and resulted in the EndMT effect on HUVECs. CONCLUSION: The PSC-Fe(2)O(3) was capable of inducing EndMT in the endothelial cells at acutely non-cytotoxic dose due to its intrinsic peroxidase-like activity, though they were few taken up by endothelial cell. The EndMT effect on HUVEC can be rescued by ROS scavenger in vitro and in vivo. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12989-019-0314-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6626375
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66263752019-07-23 Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations Wen, Tao Du, Lifan Chen, Bo Yan, Doudou Yang, Aiyun Liu, Jian Gu, Ning Meng, Jie Xu, Haiyan Part Fibre Toxicol Research BACKGROUND: Iron oxide nanoparticles (IONPs) have been extensively studied in different biomedical fields. Recently, the non-cytotoxic concentration of IONPs induced cell-specific response raised concern of their safety. Endothelial cell exposure was unavoidable in their applications, while whether IONPs affect the phenotype of vascular endothelial cells is largely unknown. In this work, the effect of IONPs on endothelial-to-mesenchymal transition (EndMT) was investigated in vitro and in vivo. RESULTS: The incubation with γ-Fe(2)O(3) nanoparticles modified with polyglucose sorbitol carboxymethyether (PSC-Fe(2)O(3)) at non-cytotoxic concentration induced morphological changes of human umbilical vein endothelial cells (HUVECs) from cobblestone-like to spindle mesenchymal-like morphology, while PSC-Fe(2)O(3) mostly stay in the culture medium and intercellular space. At the same time, the endothelial marker CD31 and VE-cadherin was decreased along with the inhibitory of angiogenesis properties of HUVEC. Meanwhile, the mesenchymal marker α-smooth muscle actin (α-SMA) and fibroblast specific protein (FSP) was up regulated significantly, and the migration ability of the cells was enhanced. When ROS scavenger mannitol or AA was supplemented, the EndMT was rescued. Results from the in vivo study showed that, expression of CD31 was decreased and α-SMA increased in the liver, spleen and kidney of mice given PSC-Fe(2)O(3), and the density of collagen fibers in the liver sinusoid of mice was increased. The supplementary mannitol or AA could reverse the degree of EndMT in the tissues. Mechanistic study in vitro indicated that the level of extracellular hydroxyl radicals (·OH) was up regulated significantly by PSC-Fe(2)O(3), which induced the response of intracellular ROS and resulted in the EndMT effect on HUVECs. CONCLUSION: The PSC-Fe(2)O(3) was capable of inducing EndMT in the endothelial cells at acutely non-cytotoxic dose due to its intrinsic peroxidase-like activity, though they were few taken up by endothelial cell. The EndMT effect on HUVEC can be rescued by ROS scavenger in vitro and in vivo. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12989-019-0314-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-12 /pmc/articles/PMC6626375/ /pubmed/31300057 http://dx.doi.org/10.1186/s12989-019-0314-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wen, Tao
Du, Lifan
Chen, Bo
Yan, Doudou
Yang, Aiyun
Liu, Jian
Gu, Ning
Meng, Jie
Xu, Haiyan
Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations
title Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations
title_full Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations
title_fullStr Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations
title_full_unstemmed Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations
title_short Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations
title_sort iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626375/
https://www.ncbi.nlm.nih.gov/pubmed/31300057
http://dx.doi.org/10.1186/s12989-019-0314-4
work_keys_str_mv AT wentao ironoxidenanoparticlesinducereversibleendothelialtomesenchymaltransitioninvascularendothelialcellsatacutelynoncytotoxicconcentrations
AT dulifan ironoxidenanoparticlesinducereversibleendothelialtomesenchymaltransitioninvascularendothelialcellsatacutelynoncytotoxicconcentrations
AT chenbo ironoxidenanoparticlesinducereversibleendothelialtomesenchymaltransitioninvascularendothelialcellsatacutelynoncytotoxicconcentrations
AT yandoudou ironoxidenanoparticlesinducereversibleendothelialtomesenchymaltransitioninvascularendothelialcellsatacutelynoncytotoxicconcentrations
AT yangaiyun ironoxidenanoparticlesinducereversibleendothelialtomesenchymaltransitioninvascularendothelialcellsatacutelynoncytotoxicconcentrations
AT liujian ironoxidenanoparticlesinducereversibleendothelialtomesenchymaltransitioninvascularendothelialcellsatacutelynoncytotoxicconcentrations
AT guning ironoxidenanoparticlesinducereversibleendothelialtomesenchymaltransitioninvascularendothelialcellsatacutelynoncytotoxicconcentrations
AT mengjie ironoxidenanoparticlesinducereversibleendothelialtomesenchymaltransitioninvascularendothelialcellsatacutelynoncytotoxicconcentrations
AT xuhaiyan ironoxidenanoparticlesinducereversibleendothelialtomesenchymaltransitioninvascularendothelialcellsatacutelynoncytotoxicconcentrations